In this study we analyzed the clinical relevance of SPANXA in lung cancer patients by using the published microarray dataset and Taiwan lung cancer cohort with real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). This evidence concerns the gene SPANXA2 and lung carcinoma.